Schedule 13D ownership disclosure
DA32 Life Science Tech Acquisition Corp.
Security class unavailable · CUSIP: 23312M106
Event date: 2023-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 90.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-23-000410
- Form type
- SC 13D
- Filer
- ARCH Venture Fund XI, L.P.
- CIK
- CIK 1831802
- Filed
- Aug 04, 2023
- Reporting period
- Jul 28, 2023
- Description
- Schedule 13D beneficial ownership